Isofagomine tartrate
From Self-sufficiency
File:Isofagomine tartrate structure.svg | |
Systematic (IUPAC) name | |
---|---|
(3R,4R,5R)-3,4-Dihydroxy-5-(hydroxymethyl)piperidine L-(+)-tartrate | |
Clinical data | |
Routes of administration | Oral |
Identifiers | |
CAS Number | 957230-65-8 |
ATC code | none |
PubChem | CID 23581846 |
Synonyms | AT-2101, HGT-3410 |
Chemical data | |
Formula | C10H19NO9 |
Molar mass | 297.25916 g/mol[[Script error: No such module "String".]] |
Script error: No such module "collapsible list". |
Isofagomine tartrate (planned trade name Plicera) is an experimental drug for the treatment of certain forms of Gaucher's disease, developed by Amicus Therapeutics and Shire plc.[1] It has been granted orphan drug status by the EMEA.[2]
Mechanism of action
β-glucocerebrosidase, an enzyme needed for the metabolisation of glucocerebroside, is misfolded in individuals with Gaucher's disease due to various mutations, one of which is called N370S. Isofagomine binds selectively to N370S glucocerebrosidase and restores its correct conformation and, consequently, enhances its activity about threefold.[3][4]
See also
- Imiglucerase, a recombinant human β-glucocerebrosidase for enzyme replacement therapy of Gaucher's disease
- Miglustat, another orphan drug for the treatment of Gaucher's disease with a different mechanism of action
References
Cite error: Invalid <references>
tag;
parameter "group" is allowed only.
<references />
, or <references group="..." />
This pharmacology-related article is a stub. You can help ssf by expanding it. |
- ↑ H. Spreitzer (20 June 2009). "Neue Wirkstoffe - Isofagomin tartrat". Österreichische Apothekerzeitung (in German) (13/2009): 736.
- ↑ Public summary of positive opinion for orphan designation of isofagomine tartrate for the treatment of Gaucher disease
- ↑ Dulsat, C., Mealy, N. (2009). "Isofagomine tartrate". Drugs of the Future. 34 (1): 23. doi:10.1358/dof.2009.034.01.1323946.
- ↑ Richard A. Steet, Stephen Chung, Brandon Wustman, Allan Powe, Hung Do, and Stuart A. Kornfeld (2006). "The iminosugar isofagomine increases the activity of N370S mutant acid β-glucosidase in Gaucher fibroblasts by several mechanisms". PNAS. 103 (37): 13813–13818. doi:10.1073/pnas.0605928103. PMC 1564243 Freely accessible. PMID 16945909.
Categories:
- Pages with script errors
- Pages with broken file links
- Infobox drug tracked parameters
- Articles without EBI source
- Chemical pages without ChemSpiderID
- Chemical pages without DrugBank identifier
- Articles without KEGG source
- Articles without InChI source
- Articles without UNII source
- Drugs not assigned an ATC code
- Drugs with no legal status
- Articles containing unverified chemical infoboxes
- Pharmacology stubs
- Orphan drugs
- 2Fix
- CS1 maint: Unrecognized language
- CS1 maint: Multiple names: authors list